Neurodiagnostic Testing Solutions
Designed to complement clinical evaluation and diagnostic testing by providing frontline objective biological data to support the assessment of neurological function and change.
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neural-Injury Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neuroendocrine Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Neurodiagnostic Testing Solutions
Designed to complement clinical evaluation and diagnostic testing by providing frontline objective biological data to support the assessment of neurological function and change.
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neuroendocrine Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neural-Injury Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
